Literature DB >> 28377486

P2X7 Deficiency Blocks Lesional Inflammasome Activity and Ameliorates Atherosclerosis in Mice.

Peter Stachon1, Adrian Heidenreich2, Julian Merz2, Ingo Hilgendorf2, Dennis Wolf2, Florian Willecke2, Sunaina von Garlen2, Philipp Albrecht2, Carmen Härdtner2, Nicolas Ehrat2, Natalie Hoppe2, Jochen Reinöhl2, Constantin von Zur Mühlen2, Christoph Bode2, Marco Idzko2, Andreas Zirlik2.   

Abstract

BACKGROUND: Extracellular adenosine triphosphate (ATP) binds as a danger signal to purinergic receptor P2X7 and promotes inflammasome assembly and interleukin-1β expression. We hypothesized a functional role of the signal axis ATP-P2X7 in inflammasome activation and the chronic inflammation driving atherosclerosis.
METHODS: P2X7-competent and P2X7-deficient macrophages were isolated and stimulated with lipopolysaccharide, ATP, or both. To assess whether P2X7 may have a role in atherosclerosis, P2X7 expression was analyzed in aortic arches from low density lipoprotein receptor-/- mice consuming a high-cholesterol or chow diet. P2X7+/+ and P2X7-/- low density lipoprotein receptor-/- mice were fed a high-cholesterol diet to investigate the functional role of P2X7 knockout in atherosclerosis. Human plaques were derived from carotid endarterectomy and stained against P2X7.
RESULTS: Lipopolysaccharide or ATP stimulation alone did not activate caspase 1 in isolated macrophages. However, priming with lipopolysaccharide, followed by stimulation with ATP, led to an activation of caspase 1 and interleukin-1β in P2X7-competent macrophages. In contrast, P2X7-deficient macrophages showed no activation of caspase 1 after sequential stimulation while still expressing a basal amount of interleukin-1β. P2X7 receptor was higher expressed in murine atherosclerotic lesions, particularly by lesional macrophages. After 16 weeks of a high-cholesterol diet, P2X7-deficient mice showed smaller atherosclerotic lesions than P2X7-competent mice (0.162 cm2±0.023 [n=9], P2X7-/- low density lipoprotein receptor-/- : 0.084 cm2±0.01 [n=11], P=0.004) with a reduced amount of lesional macrophages. In accord with our in vitro findings, lesional caspase 1 activity was abolished in P2X7-/- mice. In addition, intravital microscopy revealed reduced leukocyte rolling and adhesion in P2X7-deficient mice. Last, we observe increased P2X7 expression in human atherosclerotic lesions, suggesting that our findings in mice are relevant for human disease.
CONCLUSIONS: P2X7 deficiency resolved plaque inflammation by inhibition of lesional inflammasome activation and reduced experimental atherosclerosis. Therefore, P2X7 represents an interesting potential new target to combat atherosclerosis.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  P2X7; atherosclerosis; inflammasome; inflammation; macrophages

Mesh:

Substances:

Year:  2017        PMID: 28377486     DOI: 10.1161/CIRCULATIONAHA.117.027400

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Purinoceptor: a novel target for hypertension.

Authors:  Xuan Li; Li-Juan Zhu; Jing Lv; Xin Cao
Journal:  Purinergic Signal       Date:  2022-02-18       Impact factor: 3.765

Review 2.  Purinergic receptors mediate endothelial dysfunction and participate in atherosclerosis.

Authors:  Xian-Ming Wu; Ning Zhang; Jiang-Shan Li; Zhi-Hong Yang; Xiao-Lou Huang; Xiao-Fang Yang
Journal:  Purinergic Signal       Date:  2022-01-03       Impact factor: 3.765

3.  Plasma and aqueous humor levels of adiponutrin and pannexin 1 in patients with and without diabetic retinopathy.

Authors:  Fatih Cem Gül; Sabiha Güngör Kobat; Fatih Çelik; Süleyman Aydin; Ramazan Fazil Akkoç
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

Review 4.  Targeting innate immunity-driven inflammation in CKD and cardiovascular disease.

Authors:  Thimoteus Speer; Stefanie Dimmeler; Stefan J Schunk; Danilo Fliser; Paul M Ridker
Journal:  Nat Rev Nephrol       Date:  2022-09-05       Impact factor: 42.439

Review 5.  Inflammasomes: a preclinical assessment of targeting in atherosclerosis.

Authors:  Jeremiah Stitham; Astrid Rodriguez-Velez; Xiangyu Zhang; Se-Jin Jeong; Babak Razani
Journal:  Expert Opin Ther Targets       Date:  2020-08-06       Impact factor: 6.902

6.  Elevated circulating level of P2X7 receptor is related to severity of coronary artery stenosis and prognosis of acute myocardial infarction.

Authors:  Xiang-Xiang Shi; Kang-Chun Zheng; Pei-Ren Shan; Lei Zhang; Sheng-Jie Wu; Zhou-Qing Huang
Journal:  Cardiol J       Date:  2020-05-21       Impact factor: 2.737

7.  Atheroprone flow activates inflammation via endothelial ATP-dependent P2X7-p38 signalling.

Authors:  Jack P Green; Celine Souilhol; Ioannis Xanthis; Laura Martinez-Campesino; Neil P Bowden; Paul C Evans; Heather L Wilson
Journal:  Cardiovasc Res       Date:  2018-02-01       Impact factor: 10.787

Review 8.  Novel Insights Into the NLRP 3 Inflammasome in Atherosclerosis.

Authors:  Ying Jin; Jian Fu
Journal:  J Am Heart Assoc       Date:  2019-06-11       Impact factor: 5.501

9.  Extracellular ATP Activates the NLRP3 Inflammasome and Is an Early Danger Signal of Skin Allograft Rejection.

Authors:  Joaquín Amores-Iniesta; Maria Barberà-Cremades; Carlos M Martínez; José A Pons; Beatriz Revilla-Nuin; Laura Martínez-Alarcón; Francesco Di Virgilio; Pascual Parrilla; Alberto Baroja-Mazo; Pablo Pelegrín
Journal:  Cell Rep       Date:  2017-12-19       Impact factor: 9.423

Review 10.  New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases.

Authors:  Liliana Maria Sanmarco; Natalia Eberhardt; Nicolás Eric Ponce; Roxana Carolina Cano; Gustavo Bonacci; Maria Pilar Aoki
Journal:  Front Immunol       Date:  2018-01-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.